2024-514745-10-00CompletedPhase 1
A Study of PF-08046031 in Adults With Advanced Melanoma and Other Solid Tumors
Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 Jun 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 58 (actual)
- First submitted
- 29 Jan 2025
- Start date
- 23 Jun 2025
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2024-514745-10-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 58
- 5 sites in 5 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (5)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charite Universitaetsmedizin Berlin KöR | Berlin | Germany | Completed |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Completed |
| Institut Gustave Roussy | Villejuif | France | Completed |
| Netherlands Cancer Institute | Amsterdam | Netherlands | Completed |
| Karolinska University Hospital | Solna | Sweden | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.